Scholarlink

Background <p><i>PRRT2</i> is associated with autosomal dominant paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE) and other diseases.</p> Objective <p>To explore the phenotypic spectrum associated with <i>PRRT2</i> mutations, we analyzed a patient carrying a 16p11.2 deletion including <i>PRRT2</i>.</p> Methods <p>A retrospective analysis was conducted on the clinical and genetic characteristics of a patient with a 16p11.2 deletion containing <i>PRRT2</i>. A literature search was performed in CNKI, Wanfang, and PubMed from the establishment of the databases to December 2025, using the keywords "acute encephalopathy", "<i>PRRT2</i>", "paroxysmal non-kinesigenic dyskinesia", "ataxia", "copy number variation of chromosome 16", and "16p11.2 deletion", to identify case reports similar to the present case.</p> Result <p>This patient presented with infection-induced acute encephalopathy, acute-onset non-motor-induced movement disorders and ataxia phenotype. Genetic testing indicated a 16p11.2 deletion involving <i>PRRT2</i>, de novo. After immunotherapy and rehabilitation treatment, the patient achieved a favorable prognosis. Literature review identified only two complete international case reports similar to this case (specifically regarding ataxia), and genetic analysis showed that they were respectively a 16p11.2 deletion containing <i>PRRT2</i> and a <i>PRRT2</i> gene variation.</p> Conclusion <p>The 16p11.2 deletion containing <i>PRRT2</i> has been reported for the first time to present as an acute encephalopathy phenotype. Rare cases of paroxysmal non-motor-induced movement disorder (PNKD) and ataxia have also been reported. These findings underscore the importance of timely genetic testing and appropriate genetic counseling for patients presenting with unexplained acute encephalopathy and/or acute episodic non-motor-induced movement disorders, as well as those with ataxia symptoms.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

One case of acute encephalopathy associated with 16p11.2 deletion and PRRT2 gene mutation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月30日

查看全文
  • SiYu Shang,
  • QiuHong Wang,
  • JiaNing Wang,
  • HuiFang Song,
  • Jiao Zhang,
  • XiaoYang Liu,
  • Xin Gao,
  • ChangHong Ding

摘要

Background

PRRT2 is associated with autosomal dominant paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE) and other diseases.

Objective

To explore the phenotypic spectrum associated with PRRT2 mutations, we analyzed a patient carrying a 16p11.2 deletion including PRRT2.

Methods

A retrospective analysis was conducted on the clinical and genetic characteristics of a patient with a 16p11.2 deletion containing PRRT2. A literature search was performed in CNKI, Wanfang, and PubMed from the establishment of the databases to December 2025, using the keywords "acute encephalopathy", "PRRT2", "paroxysmal non-kinesigenic dyskinesia", "ataxia", "copy number variation of chromosome 16", and "16p11.2 deletion", to identify case reports similar to the present case.

Result

This patient presented with infection-induced acute encephalopathy, acute-onset non-motor-induced movement disorders and ataxia phenotype. Genetic testing indicated a 16p11.2 deletion involving PRRT2, de novo. After immunotherapy and rehabilitation treatment, the patient achieved a favorable prognosis. Literature review identified only two complete international case reports similar to this case (specifically regarding ataxia), and genetic analysis showed that they were respectively a 16p11.2 deletion containing PRRT2 and a PRRT2 gene variation.

Conclusion

The 16p11.2 deletion containing PRRT2 has been reported for the first time to present as an acute encephalopathy phenotype. Rare cases of paroxysmal non-motor-induced movement disorder (PNKD) and ataxia have also been reported. These findings underscore the importance of timely genetic testing and appropriate genetic counseling for patients presenting with unexplained acute encephalopathy and/or acute episodic non-motor-induced movement disorders, as well as those with ataxia symptoms.